We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
We've found
6,367
archived clinical trials in
High Blood Pressure (Hypertension)
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Trial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial Hypertension
Updated: 12/31/1969
A Phase III, International, Multi-Center, Randomized, Double- Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension With Acoustic Radiation Force Impulse (ARFI)
Updated: 12/31/1969
Non-invasive Diagnosis of Portal Hypertension by Acoustic Radiation Force Impulse (ARFI) Imaging of the Liver and Spleen in Patients With Chronic Liver Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Updated: 12/31/1969
Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
Status: Enrolling
Updated: 12/31/1969
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
Updated: 12/31/1969
Calcium Channel Blockers in Nitric Oxide Non-responder Pulmonary Arterial Hypertension.
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Adult Congenital Heart Disease Registry (QuERI)
Updated: 12/31/1969
Adult Congenital Heart Disease Quality Enhancement Research Initiative
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials